CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma

(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high rate of non-relapse mortality in patients with multiple myeloma, according to a retrospective study…

Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/119503

Author :

Publish date : 2026-01-20 21:07:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma

Study: Helping Lupus Patients With Money Issues Improves Their Health

Parent-Led Intervention Started in NICU Boosted Executive Function at School Age

Related Posts

Microplastics Detected in Prostate Tumor Samples

The 3 things you need to know about passwords, from a security expert

Corporate ED Clash; Trimester Zero; Who Americans Trust on Public Health

NIH Funds Still Not Getting to Researchers

Intraperitoneal Insulin an Option for Select T1D Patients

Meningitis Risk for Young Adults With Chikungunya Vaccine

Microplastics Detected in Prostate Tumor Samples

The 3 things you need to know about passwords, from a security expert

Corporate ED Clash; Trimester Zero; Who Americans Trust on Public Health

NIH Funds Still Not Getting to Researchers

Intraperitoneal Insulin an Option for Select T1D Patients

Meningitis Risk for Young Adults With Chikungunya Vaccine

If Medical Schools Can Make Room for Nutrition, Why Not Women’s Health?

William Shatner’s Surgery; ‘Brain Dead’ Woman Wakes Up; Near-Fatal Measles Case

Categories

Archives